Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Episode | Date |
---|---|
Peter Lio, MD - AI in Healthcare: A Primer for the Practicing Clinician
|
Apr 05, 2024 |
Peter Lio, MD - Generative AI: Benefits for Your Practice, for Your Patients
|
Apr 05, 2024 |
Nikhil I. Khushalani, MD - Pointing the Way to Enhanced Outcomes in Resectable Cutaneous Squamous Cell Carcinoma: Practical Strategies to Incorporate Neoadjuvant Immunotherapy
|
Feb 26, 2024 |
Evan J. Lipson, MD - Real Talk About Maximizing Care in Advanced Melanoma: Balancing Benefit and Risk Using Dual Immunotherapy Regimens
|
Feb 14, 2024 |
Jonathan Barker, BSc, MB, BS, MD, FRCP - Novel Approved and Emerging IL-36 Receptor Inhibitors for the Treatment of GPP
|
Jan 26, 2024 |
David M. Miller, MD, PhD / Kevin Emerick, MD - Coming Together to Improve Outcomes in Resectable Cutaneous Squamous Cell Carcinoma: Multidisciplinary Care Strategies With Neoadjuvant Immunotherapy
|
Jan 03, 2024 |
Vishal A. Patel, MD - Making Headway in Treating Resectable Cutaneous Squamous Cell Carcinoma: Setting Sights on Neoadjuvant Immunotherapy
|
Dec 18, 2023 |
Trisha Wise-Draper, MD, PhD - Empowering Precision Decisions: PD-1 Inhibitor-Based Therapies and Biomarker Testing in R/M HNSCC
|
Oct 11, 2023 |
Shawn Kwatra, MD - Itching for Relief: Exploring the Role of Novel Biologics in Prurigo Nodularis
|
Oct 06, 2023 |
Sapna P. Patel, MD - Enhancing Neoadjuvant and Adjuvant Treatment in Resectable Melanoma: Is Timing the Key to Improved Outcomes?
|
Sep 19, 2023 |
Peter Lio, MD - Enriching Care for Pediatric Atopic Dermatitis: Evidence-Based Strategies for Integrating Targeted Systemic Therapies
|
Aug 23, 2023 |
April W. Armstrong, MD, MPH - Looking Ahead: What the Future Holds for Novel Systemic Therapies in the Treatment of Moderate-to-Severe Atopic Hand and Foot Dermatitis
|
Jul 03, 2023 |
Axel Hauschild, MD - Advancing Outcomes in Surgically Resectable Cutaneous Squamous Cell Carcinoma: Carving New Paths Forward With Immunotherapies
|
Jun 15, 2023 |
Dirk Schadendorf, MD - An Evolution in Care for Advanced Melanoma: Exploring the Clinical Implications of Approved and Emerging Anti–LAG-3/PD-1 Combinations
|
Jun 08, 2023 |
Hussein Tawbi, MD, PhD / Laura K. Ferris, MD, PhD - Optimizing Outcomes in Advanced Melanoma Through Enhanced Collaboration: A Real-World Multidisciplinary Approach
|
May 04, 2023 |
Reinhard Dummer, Prof. Dr. med - Making the Case for a Systemic Approach to Advanced Basal Cell Carcinoma: A Multidisciplinary Team Strategy to Optimize Long-Term Care
|
Mar 30, 2023 |
Brian S. Kim, MD - Scratching the Itch: Biologic Breakthroughs in Prurigo Nodularis
|
Mar 16, 2023 |
Bruce E. Strober, MD, PhD - Patient Conversations in Plaque Psoriasis: Discussing Novel TYK2 Inhibitors for the Treatment of Patients Who Are Candidates for Systemic Therapy
|
Mar 16, 2023 |
Omid Hamid, MD - An Expert Conversation About Anti-LAG-3/PD-1 Combinations: Exploring the Clinical Impact of Approved and Emerging Combinations in the Advanced Melanoma Treatment Landscape
|
Dec 20, 2022 |
Todd Schlesinger, MD, FAAD - Optimizing Immunotherapy in Patients With Advanced Basal Cell Carcinoma: Practical Strategies to Inform Care
|
Dec 13, 2022 |
Peter Lio, MD - More Than Scratching the Surface: Optimizing Novel JAK Inhibitors for Improved Outcomes in Moderate-to-Severe Atopic Dermatitis
|
Dec 05, 2022 |
Latanya Benjamin, MD, FAAD, FAAP - Improving the Care of Children with Moderate-to-Severe Atopic Dermatitis: When and How to Intensify Treatment with Novel Systemic Agents
|
Nov 16, 2022 |
Tanios Bekaii-Saab, MD / Beth McLellan, MD - Managing Hand-Foot Skin Reaction: Interdisciplinary Strategies for Patients on Multikinase Inhibitors
|
Oct 04, 2022 |
Ikuo Hirano, MD - Closing In on Improved Quality of Life for Patients With Eosinophilic Esophagitis by Diagnosing Promptly and Understanding Type 2 Inflammation
|
Sep 26, 2022 |
Peter Lio, MD - Clinical Perspective on the Latest Data for Emerging Therapies Targeting IL-13 in Moderate-to-Severe Atopic Dermatitis
|
Sep 02, 2022 |